Combined inhalers vs placebo (outcomes
Annual Exacerbation Rates · COPD
Combined inhalers probably leads to lower annual exacerbation rates compared with placebo (primary outcomes) (moderate certainty).
1 finding from 1 review
- Combined corticosteroid and long‐acting beta₂‐agonist in one inhaler versus placebo for chronic obstructive pulmonary… 2013 · Cochrane Headline outcomes onlyRate ratio 0.73 [0.69, 0.78]7473 participantsModerate